Bevacizumab 71124-0039-00
- Manufacturer
- Samsung Biologics Co. Ltd
- Dosage Form
- Injection
- Product Type
- Drug For Further Processing
- Marketing Start
- September 24, 2024
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Bevacizumab-Adcd | 25 mg/mL |
Selected Package
71124-0039-00Selected4 mL in 1 VIAL, GLASS (71124-0039-0)
Other packages for this product(1)
16 mL in 1 VIAL, GLASS (71124-0039-1)